1 | and dry syrup formulations | | | | | | | 2 | 0.49% |
2 | dry syrup external syrup | | | | | | | 2 | 0.49% |
3 | betalactam capsules non betalactam | | | | | | | 2 | 0.49% |
4 | ßlactum beta lactum and | | | | | | | 2 | 0.49% |
5 | high quality ßlactum beta | | | | | | | 2 | 0.49% |
6 | m sea pharmaceuticals pvt | | | | | | | 2 | 0.49% |
7 | suspension solution tablets betalactam | | | | | | | 2 | 0.49% |
8 | m sea pharma is | | | | | | | 2 | 0.49% |
9 | drops dry syrup external | | | | | | | 2 | 0.49% |
10 | at m sea pharma | | | | | | | 2 | 0.49% |
11 | range of high quality | | | | | | | 1 | 0.25% |
12 | wider range of high | | | | | | | 1 | 0.25% |
13 | of wider range of | | | | | | | 1 | 0.25% |
14 | manufacturing services of wider | | | | | | | 1 | 0.25% |
15 | services of wider range | | | | | | | 1 | 0.25% |
16 | lactum oral liquid syrup | | | | | | | 1 | 0.25% |
17 | in contract third party | | | | | | | 1 | 0.25% |
18 | engaged in contract third | | | | | | | 1 | 0.25% |
19 | are engaged in contract | | | | | | | 1 | 0.25% |
20 | pharma are engaged in | | | | | | | 1 | 0.25% |
21 | sea pharma are engaged | | | | | | | 1 | 0.25% |
22 | m sea pharma are | | | | | | | 1 | 0.25% |
23 | manufacturing m sea pharma | | | | | | | 1 | 0.25% |
24 | of high quality ßlactum | | | | | | | 1 | 0.25% |
25 | m sea pharmaceuticals private | | | | | | | 1 | 0.25% |
26 | oral liquid syrup and | | | | | | | 1 | 0.25% |
27 | committed to operating with | | | | | | | 1 | 0.25% |
28 | and commercializing innovative products | | | | | | | 1 | 0.25% |
29 | developing and commercializing innovative | | | | | | | 1 | 0.25% |
30 | patients lives by identifying | | | | | | | 1 | 0.25% |
31 | improve patients lives by | | | | | | | 1 | 0.25% |
32 | to improve patients lives | | | | | | | 1 | 0.25% |
33 | dedication to improve patients | | | | | | | 1 | 0.25% |
34 | and dedication to improve | | | | | | | 1 | 0.25% |
35 | integrity and dedication to | | | | | | | 1 | 0.25% |
36 | is committed to operating | | | | | | | 1 | 0.25% |
37 | syrup formulations p2pcontractthird party | | | | | | | 1 | 0.25% |
38 | pharma is committed to | | | | | | | 1 | 0.25% |
39 | sea pharma is committed | | | | | | | 1 | 0.25% |
40 | team at m sea | | | | | | | 1 | 0.25% |